• Home
  • Journal
  • Public Companies
  • Spineway : Signature of an exclusive agreement with the Japanese distributor MURANAKA Medical Instruments

Spineway : Signature of an exclusive agreement with the Japanese distributor MURANAKA Medical Instruments

Signature of an exclusive agreement with the Japanese distributor MURANAKA Medical InstrumentsSpineway, specialist in designing innovative surgical implants and instruments for treating severe disorders of the spinal column, announces the signature of an exclusive agreement for the distribution of its products in Japan with MURANAKA Medical Instruments.This agreement follows on the heels of the approval last October by the Japanese health authorities of Spineway’s Mont-Blanc MIS minimally invasive surgical line. Thanks to established know-how on the Asian continent, Spineway will be able to rely on the sales network and expertise of one of the biggest importers/distributers of medical equipment in Japan to distribute its products on this territory.Based in Osaka, MURANAKA boasts annual revenue of over 300 million euros and is established in Japan’s largest cities. It has a neurosurgery division and distributes a wide range of equipment and consumables (implants) to the main Japanese hospitals.Stéphane Le Roux, Chairman and CEO of Spineway, said: “We are honored by and pleased with this partnership with MURANAKA, which is the best partner possible for the promotion of our Mont-Blanc MIS line in Japan. As soon as is feasible, we will assist MURANAKA’s teams and provide guidance as to the specifics and advantages of the Spineway systems in order to develop sales of our premium implants in Japan.”Thanks to this agreement, Spineway will be able to distribute its implants on one of the world’s largest spinal-surgery markets and spur its sales with higher added value.Upcoming: 26 May 2020 – General MeetingSPINEWAY IS ELIGIBLE FOR THE PEA-PME (EQUITY SAVINGS PLANS FOR SMES)Find out all about Spineway at www.spineway.comThis press release has been prepared in both English and French. In case of discrepancies, the French version shall prevail.Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column.
Spineway has an international network of over 50 independent distributors and 90% of its revenue comes from exports.
Spineway, which is eligible for investment through FCPIs (French unit trusts specializing in innovation), has received the OSEO Excellence award since 2011 and has won the Deloitte Fast 50 award (2011). Rhône Alpes INPI Patent Innovation award (2013) – INPI Talent award (2015).
ISIN: FR0011398874 – ALSPW
Contacts:AttachmentCP_SPW_Japon_VD 202004 GB

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.